ISSN:
1619-7089
Keywords:
Benzodiazepine
;
Dynamic single-photon emission tomography
;
Iodine-123-3-(5-cyclopropyl1,2,4-oxadiazo-3-yl)-7-iodo-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]-benzodiazepine
;
Receptors
;
NNC 13-8241
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract The iodine-123 labelled ligand 3-(5-cyclopropyl-1,2,4-oxadiazo-3-yl)-7-iodo-5,6-dihydro-5-methyl-6oxo-4H-imidazo[1,5-a][1,4]-benzodiazepine ([123I]NNC 13-8241) was evaluated as a probe for in vivo imaging of benzodiazepine receptor sites in the human brain. Four healthy volunteers were imaged with a high-resolution single-photon emission tomography (SPET) scanner. The metabolism of [123I]NNC 13-8241 in plasma was slow. The total brain uptake was about 1.5-fold higher than that of [123I]iomazenil. The specific binding in the cortical areas was high and less intense in the thalamus. The most intense uptake was seen in the occipital cortex. The peak cortical uptake of [123I]NNC 13-8241 was observed 6–10 h after the injection of tracer. The radiation burden to the patient was moderate, being 2.5·10−2 mSv/MBq (effective dose equivalent). A slow metabolism together with favourable kinetics indicates that [123I]NNC 13-8241 is a specific and promising SPET ligand for imaging benzodiazepine receptor sites in the living human brain.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF00843709
Permalink